SCHEMBL27242014

SCHEMBL27242014

Cc1cn2nc(-c3nc4ccc(N5CCN(C(=O)O)CC5)cc4c(=O)[nH]3)cc2c(C)n1

nearest known ligand 0.45

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.45
ALDH1A1 P00352 2/20 0.45
MAPT P10636 2/20 0.45
MEN1 O00255 1/20 0.43
POLB P06746 1/20 0.43
HPGD P15428 1/20 0.43
KMT2A Q03164 1/20 0.43
TNKS O95271 1/20 0.42
PARP1 P09874 1/20 0.42
TNKS2 Q9H2K2 1/20 0.42
MGLL Q99685 6/20 0.37
PDE3B Q13370 1/20 0.36
PDE3A Q14432 1/20 0.36
IP6K1 Q92551 2/20 0.36
IP6K3 Q96PC2 1/20 0.36
STAT3 P40763 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23293768 0.90 KDM4E (0.56) KDM4EALDH1A1MAPTMEN1POLB
SCHEMBL29800261 0.90 KDM4E (0.56) KDM4EALDH1A1MAPTMEN1POLB
SCHEMBL30947730 0.89 MAPT (0.43) KDM4EALDH1A1MAPTMEN1POLB
SCHEMBL23316231 0.89 MAPT (0.43) KDM4EALDH1A1MAPTMEN1POLB
Hydrochloric Acid SCHEMBL23293837 0.89 KDM4E (0.56) KDM4EALDH1A1MAPTMEN1POLB
SCHEMBL23293858 0.88 KDM4E (0.45) KDM4EALDH1A1MAPTMEN1POLB
Succinic Acid SCHEMBL23293781 0.88 KDM4E (0.51) KDM4EALDH1A1MAPTMEN1POLB
SCHEMBL23293821 0.87 KDM4E (0.45) KDM4EALDH1A1MAPTMEN1POLB
SCHEMBL29800591 0.87 KDM4E (0.45) KDM4EALDH1A1MAPTMEN1POLB
SCHEMBL23316314 0.87 KDM4E (0.45) KDM4EALDH1A1MAPTMEN1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12012410-B2 Substituted pyrazolo[1,5-a]pyrazines for spinal muscular atrophy REBORNA BIOSCIENCES, INC. (JP) 2024-06-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12012410-B2 Substituted pyrazolo[1,5-a]pyrazines for spinal muscular atrophy SMN1; SMN2, HDAC5, PUM1 KDM4E 1818/4885ALDH1A1 1801/4885MAPT 373/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.